Back
Intellia Therapeutics Vs. John Wiley & Sons Industry Stock Comparison
Sell
16
NTLA
Intellia Therapeutics
Last Price:
21.02
Seasonality Move:
8.84%
Sell
43
WLY
John Wiley & Sons
Last Price:
48.06
Seasonality Move:
2.42%
Sell
16
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
- The current Intellia Therapeutics [NTLA] share price is $20.57. The Score for NTLA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- NTLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
John Wiley & Sons (WLY)
is a Sell
Is John Wiley & Sons a Buy, Sell or Hold?
- The current John Wiley & Sons [WLY] share price is $47.13. The Score for WLY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- WLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $20.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing slight selling pressure.
WLY Stock Price Chart
What is John Wiley & Sons's stock price today?
-
The John Wiley & Sons share price today is $47.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
NTLA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.39 | Sell |
| Relative Strength Index (14 RSI): | 40.96 | Sell |
| Chaikin Money Flow: | -540966 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.58 - 22.86) | Sell |
| Bollinger Bands (100): | (21.68 - 25.4) | Sell |
WLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 56.66 | Buy |
| Chaikin Money Flow: | 223333 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.61 - 47.69) | Buy |
| Bollinger Bands (100): | (38.86 - 47) | Buy |
NTLA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.76 | Sell |
| 20-day SMA: | 21.37 | Sell |
| 50-day SMA: | 22.88 | Sell |
| 200-day SMA: | 25.29 | Sell |
| 8-day EMA: | 21.31 | Sell |
| 20-day EMA: | 21.63 | Sell |
| 50-day EMA: | 22.44 | Sell |
| 200-day EMA: | 25.82 | Sell |
WLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.61 | Buy |
| 20-day SMA: | 45.98 | Buy |
| 50-day SMA: | 46.08 | Buy |
| 200-day SMA: | 38.92 | Buy |
| 8-day EMA: | 46.47 | Buy |
| 20-day EMA: | 46.14 | Buy |
| 50-day EMA: | 45.34 | Buy |
| 200-day EMA: | 40.76 | Buy |
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.19 per share.
John Wiley & Sons Earnings Growth & WLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.00 per share, and an increase next year of $0.26 per share.
Intellia Therapeutics Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
John Wiley & Sons Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||